© 2021 MJH Life Sciences™ and Optometry Times. All rights reserved.
Nevakar spins off ophthalmic-only company Vyluma
A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.
Navneet Puri, PhD, founder, chairman, and CEO of newly formed Vyluma discusses why Nevakar chose to make the move to ophthalmic-only pharma.
Related Content:
